[{"ID":"5378_12-2021_NCT02432196","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is excluded from the clinical trial. The patient has severe mitral regurgitation, which is listed as an exclusion criterion. Additionally, the patient has a history of gestational diabetes mellitus, hypertension during pregnancy, and obesity, which may be considered as co-morbidities that could affect the patient's participation in the study.","PROBA":0.9897078974},{"ID":"30612_65-2021_NCT01557465","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.9807452361},{"ID":"35572_75-2021_NCT02730065","TOPIC_YEAR":2021,"RESPONSE":"$}}%A%]  C: irrelevant","PROBA":0.9794453184},{"ID":"33729_71-2021_NCT02774668","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is eligible for the clinical trial. Here's a step-by-step analysis:\n\n1. Inclusion Criteria:\n\t* The patient is overweight and obese (BMI = 41.5).\n\t* The patient is willing to participate in a low-carbohydrate diet plan.\n\t* The patient has no known liver disease.\n\t* The patient has no diabetes or fasting glucose \u2265 125 mg\/dL.\n\t* The patient does not use medications that interfere with protein, carbohydrate, or lipid metabolism (e.g., fish oil capsules).\n\t* The patient does not smoke or use any drugs.\n2. Exclusion Criteria:\n\t* The patient does not have abnormal thyroid function.\n\t* The patient is not pregnant or peri-menopausal.\n\t* The patient does not have a history of gout.\n\t* The patient's hypertension is not uncontrolled.\n\nSince all inclusion criteria are met, and none of the exclusion criteria are met, the patient is eligible for the clinical trial. Therefore, the answer is A: eligible.","PROBA":0.996083509},{"ID":"5443_12-2021_NCT03278574","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA) eligible","PROBA":0.871539558},{"ID":"35560_75-2021_NCT02657681","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided in the patient note, the patient is eligible for the clinical trial. Here's a step-by-step analysis:\n\n1. Inclusion Criteria:\n\t* The patient has Parkinson's disease (as confirmed by the recent diagnosis)\n\t* The patient is experiencing levodopa-induced dyskinesias (as indicated by the offer of Levodopa and Trihexyphenidyl)\n\t* The patient is Hoehn-Yahr Stage I (mild disease)\n2. Exclusion Criteria:\n\t* There are no MRI-incompatible metal objects in the body (the patient does not have any implantable devices)\n\t* No other main neuropsychiatric co-morbidity (the patient does not have any other significant neurological or psychiatric conditions)\n\nSince all inclusion criteria are met, and none of the exclusion criteria are met, the patient is eligible for the clinical trial. Therefore, the answer is [A] eligible.","PROBA":0.9919830861},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is eligible for the clinical trial. Here's why:\n\n1. Age: The patient is 67 years old, which is within the age range of 65-75 years old specified in the inclusion criteria.\n2. Hypertension: The patient has a history of hypertension, which is one of the main risk factors for CVD and is included in the inclusion criteria.\n3. Obesity: The patient is not morbidly obese, which is an exclusion criterion.\n4. Physical inactivity: The patient is described as having slowly worsening vision, which suggests that they may be less active, and the study is focused on the effects of exercise on health indicators.\n5. No history of severe hypertension: The patient's blood pressure is 130\/70, which is not considered severe hypertension.\n6. No history of falls: The patient's physical examination is normal, and there is no mention of falls.\n7. No orthopaedic, neurological, pulmonary, or cardiac problems: The patient's physical examination is normal, and there is no mention of any of these conditions.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial. The answer is B.","PROBA":0.9889666445},{"ID":"6816_15-2021_NCT02243007","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.9981205662},{"ID":"5318_12-2021_NCT01708265","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is not eligible for the clinical trial. The patient has a known severe mitral valve prolapse with regurgitation, which is not considered asymptomatic. Additionally, the patient has a history of gestational diabetes mellitus, hypertension with pregnancy, and obesity, which may increase the surgical risks and make the patient ineligible for the study. Furthermore, the patient has a history of laser eye surgery and cataract surgery, which may not be directly related to the mitral valve condition but could potentially increase the risk of complications during the study. Therefore, based on the inclusion and exclusion criteria provided, the patient is not eligible for the Dutch Asymptomatic Mitral Regurgitation Trial.","PROBA":0.9846037823},{"ID":"14106_30-2021_NCT02526719","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.999965176},{"ID":"17449_36-2021_NCT04835558","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the patient's BMI of 41.54, the patient meets the inclusion criteria of the clinical trial. The patient has obesity, which is one of the criteria for the clinical trial. Additionally, the patient's PaCO2 level of 45 mm Hg indicates chronic daytime hypercapnia, which is another inclusion criterion. Furthermore, the patient's sleep apnea and dissatisfaction with her body shape are also relevant to the clinical trial.\n\nHowever, the patient is excluded from the clinical trial because of the exclusion criterion of severe respiratory disease. The patient's cardiac assessment is normal, which suggests that the patient does not have severe respiratory disease. Therefore, the patient is eligible for the clinical trial.\n\nSo, the final answer is B: eligible.","PROBA":0.9896854603},{"ID":"6690_15-2021_NCT01252719","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded. The patient does not have an acute bacterial skin and skin structure infection (ABSSSI) as the clinical trial is focused on treating such infections. The patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia, which are not related to ABSSSI. Additionally, the patient is being treated with IV antibiotics for suspected pancreatic abscess, which is not an inclusion criterion for the clinical trial.","PROBA":0.9979072663},{"ID":"17226_36-2021_NCT03082781","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is not eligible for the clinical trial. The patient is 32 years old, which is not within the age range of the study (elderly adult women). Additionally, the patient has a BMI of 41.54, which is outside the range of 27-40 required for inclusion in the study. Furthermore, the patient has a history of trying diets and exercise to lose weight, which is not consistent with the study's exclusion criteria of having a history of anti-obesity medication or weight loss drugs or dietary supplements for weight control. Therefore, the patient is not eligible for the clinical trial.","PROBA":0.9912114098},{"ID":"6894_15-2021_NCT02984501","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9950902984},{"ID":"13974_30-2021_NCT00677469","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, the patient has Hashimoto's thyroiditis, which is a type of hypothyroidism, not hyperthyroidism. Therefore, the patient is not eligible for the clinical trial. The clinical trial is specifically designed for patients with hyperthyroidism, and the inclusion criteria state that patients must have hyperthyroidism to be eligible.\n\nTherefore, the answer is B: excluded.","PROBA":0.9841554869},{"ID":"30893_65-2021_NCT03888664","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB: excluded","PROBA":0.9996064305},{"ID":"5310_12-2021_NCT01635244","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nA: eligible","PROBA":0.9999933773},{"ID":"17033_36-2021_NCT01492413","TOPIC_YEAR":2021,"RESPONSE":"$}}%>","PROBA":0.740872696},{"ID":"6712_15-2021_NCT01442441","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nB based on the information provided, the patient is not eligible for the clinical trial. The patient has been diagnosed with pancreatic adenocarcinoma, which is a different condition than chronic pancreatitis. The clinical trial is specifically focused on chronic pancreatitis, and excludes patients who are under the age of 18. Therefore, the patient is not eligible for the clinical trial.","PROBA":0.9817883518},{"ID":"33899_71-2021_NCT04197817","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the information provided, the patient is not eligible for the clinical trial. Here's why:\n\n1. Age: The patient is 34 years old, which is outside the age range of 18-45 years old specified in the inclusion criteria.\n2. Gender: The patient is a woman, which is not excluded in the inclusion criteria, but the study does not specify a preference for gender.\n3. BMI: The patient has a BMI of 41.5, which is outside the range of 18-30 specified in the inclusion criteria.\n4. Medical history: The patient has a history of sleep apnea, PCO, and obesity, which are all relevant to the study's focus on lipid metabolism and cardiovascular risk factors. However, the patient's history of drug use (antiobesity agents and appetite suppressants) and the presence of PCO may be exclusionary.\n5. Current medications: The patient is not taking any medications that are specified in the exclusion criteria.\n6. Other factors: The patient does not have any other factors that would exclude them from the study.\n\nTherefore, based on the information provided, the patient is not eligible for the clinical trial.","PROBA":0.988435901}]
